Endologix to Present at the 30th Annual J.P. Morgan Healthcare Conference

IRVINE, Calif., Jan. 3, 2012 (GLOBE NEWSWIRE) -- Endologix, Inc.John McDermott, President and Chief Executive Officer, is scheduled to present at the 30th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco, CA.

Event: 30th Annual J.P. Morgan Healthcare Conference
Date: Wednesday, January 11, 2012
Time: 9:30 a.m. PT/ 12:30 p.m. ET

An audio webcast of the Company's presentation will be available by visiting the investor relations section of Endologix's.  A replay of the presentation will be available for 30 days.

About Endologix, Inc.

Endologix, Inc. (the "Company") develops and manufactures minimally invasive treatments for aortic disorders. The Company's focus is endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 75%, making it a leading cause of death in the U.S.Endologix's.

Source: Endologix

News Provided by Acquire Media

distribué par

Ce noodl a été diffusé par Endologix Inc. et initialement mise en ligne sur le site http://www.endologix.com. La version originale est disponible ici.

Ce noodl a été distribué par noodls dans son format d'origine et sans modification sur 2012-01-03 23:20:56 PM et restera accessible depuis ce lien permanent.

Cette annonce est protégée par les règles du droit d'auteur et toute autre loi applicable, et son propriétaire est seul responsable de sa véracité et de son originalité.